WO2006025307A1 - シワ改善剤、脂肪分解促進剤、皮膚外用組成物及び飲食物組成物 - Google Patents
シワ改善剤、脂肪分解促進剤、皮膚外用組成物及び飲食物組成物 Download PDFInfo
- Publication number
- WO2006025307A1 WO2006025307A1 PCT/JP2005/015635 JP2005015635W WO2006025307A1 WO 2006025307 A1 WO2006025307 A1 WO 2006025307A1 JP 2005015635 W JP2005015635 W JP 2005015635W WO 2006025307 A1 WO2006025307 A1 WO 2006025307A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- extract
- skin
- ginger
- food
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 81
- 235000013305 food Nutrition 0.000 title claims description 27
- 230000004130 lipolysis Effects 0.000 title claims description 26
- 235000013361 beverage Nutrition 0.000 title claims description 20
- 230000037331 wrinkle reduction Effects 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 claims abstract description 21
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 17
- 125000002252 acyl group Chemical group 0.000 claims abstract description 12
- 239000004480 active ingredient Substances 0.000 claims abstract description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 11
- 230000037303 wrinkles Effects 0.000 claims description 43
- 241000234314 Zingiber Species 0.000 claims description 38
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 22
- 235000008397 ginger Nutrition 0.000 claims description 22
- 125000004432 carbon atom Chemical group C* 0.000 claims description 10
- 244000227206 Aframomum melegueta Species 0.000 abstract description 6
- 235000002568 Capsicum frutescens Nutrition 0.000 abstract description 2
- 238000005917 acylation reaction Methods 0.000 abstract description 2
- 239000001257 hydrogen Substances 0.000 abstract description 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract description 2
- 230000010933 acylation Effects 0.000 abstract 1
- CZNLTCTYLMYLHL-UHFFFAOYSA-N [6]-Paradol Chemical compound CCCCCCCC(=O)CCC1=CC=C(O)C(OC)=C1 CZNLTCTYLMYLHL-UHFFFAOYSA-N 0.000 description 89
- 210000003491 skin Anatomy 0.000 description 54
- 230000000694 effects Effects 0.000 description 45
- 238000004519 manufacturing process Methods 0.000 description 40
- 229940002508 ginger extract Drugs 0.000 description 34
- 235000020708 ginger extract Nutrition 0.000 description 33
- 238000012360 testing method Methods 0.000 description 29
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- 230000000052 comparative effect Effects 0.000 description 21
- 238000011156 evaluation Methods 0.000 description 19
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 239000000047 product Substances 0.000 description 18
- 210000000577 adipose tissue Anatomy 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 15
- 208000008589 Obesity Diseases 0.000 description 14
- 235000020824 obesity Nutrition 0.000 description 13
- -1 as described above Substances 0.000 description 12
- 102000008186 Collagen Human genes 0.000 description 11
- 108010035532 Collagen Proteins 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 230000032683 aging Effects 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000003205 fragrance Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 9
- 235000019629 palatability Nutrition 0.000 description 9
- 206010051246 Photodermatosis Diseases 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 230000006872 improvement Effects 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 230000008845 photoaging Effects 0.000 description 8
- 230000001737 promoting effect Effects 0.000 description 8
- OJYLAHXKWMRDGS-UHFFFAOYSA-N zingerone Chemical compound COC1=CC(CCC(C)=O)=CC=C1O OJYLAHXKWMRDGS-UHFFFAOYSA-N 0.000 description 8
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 7
- 238000013329 compounding Methods 0.000 description 7
- 235000011187 glycerol Nutrition 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 6
- YKPUWZUDDOIDPM-SOFGYWHQSA-N capsaicin Chemical compound COC1=CC(CNC(=O)CCCC\C=C\C(C)C)=CC=C1O YKPUWZUDDOIDPM-SOFGYWHQSA-N 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 235000019633 pungent taste Nutrition 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- 235000015752 Aframomum melegueta Nutrition 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 5
- 235000015218 chewing gum Nutrition 0.000 description 5
- 229940112822 chewing gum Drugs 0.000 description 5
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 5
- 230000002500 effect on skin Effects 0.000 description 5
- 229960002591 hydroxyproline Drugs 0.000 description 5
- 239000002689 soil Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 5
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 4
- XJLDYKIEURAVBW-UHFFFAOYSA-N 3-decanone Chemical compound CCCCCCCC(=O)CC XJLDYKIEURAVBW-UHFFFAOYSA-N 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 4
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 4
- 239000001726 jatropha manihot extract Substances 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 235000013599 spices Nutrition 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 229940106668 yucca extract Drugs 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- 239000004129 EU approved improving agent Substances 0.000 description 3
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 3
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- 241000234299 Zingiberaceae Species 0.000 description 3
- 210000001789 adipocyte Anatomy 0.000 description 3
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 3
- 229960001948 caffeine Drugs 0.000 description 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 3
- 235000017663 capsaicin Nutrition 0.000 description 3
- 229960002504 capsaicin Drugs 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011194 food seasoning agent Nutrition 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 235000009200 high fat diet Nutrition 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229960003471 retinol Drugs 0.000 description 3
- 235000020944 retinol Nutrition 0.000 description 3
- 239000011607 retinol Substances 0.000 description 3
- 239000002884 skin cream Substances 0.000 description 3
- 150000005846 sugar alcohols Polymers 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000009885 systemic effect Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 2
- OQWKEEOHDMUXEO-UHFFFAOYSA-N (6)-shogaol Natural products CCCCCC=CC(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-UHFFFAOYSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 2
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 2
- 239000001653 FEMA 3120 Substances 0.000 description 2
- 241000282414 Homo sapiens Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N L-glucitol Chemical compound OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 244000235659 Rubus idaeus Species 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 229910004298 SiO 2 Inorganic materials 0.000 description 2
- 208000006981 Skin Abnormalities Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 241001532059 Yucca Species 0.000 description 2
- 235000004552 Yucca aloifolia Nutrition 0.000 description 2
- 235000012044 Yucca brevifolia Nutrition 0.000 description 2
- 235000017049 Yucca glauca Nutrition 0.000 description 2
- OQWKEEOHDMUXEO-BQYQJAHWSA-N [6]-Shogaol Chemical compound CCCCC\C=C\C(=O)CCC1=CC=C(O)C(OC)=C1 OQWKEEOHDMUXEO-BQYQJAHWSA-N 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 230000001800 adrenalinergic effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000012298 atmosphere Substances 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
- 229940043276 diisopropanolamine Drugs 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- ZSIAUFGUXNUGDI-UHFFFAOYSA-N hexan-1-ol Chemical compound CCCCCCO ZSIAUFGUXNUGDI-UHFFFAOYSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- VKCYHJWLYTUGCC-UHFFFAOYSA-N nonan-2-one Chemical compound CCCCCCCC(C)=O VKCYHJWLYTUGCC-UHFFFAOYSA-N 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 230000036542 oxidative stress Effects 0.000 description 2
- VWMVAQHMFFZQGD-UHFFFAOYSA-N p-Hydroxybenzyl acetone Natural products CC(=O)CC1=CC=C(O)C=C1 VWMVAQHMFFZQGD-UHFFFAOYSA-N 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- NJGBTKGETPDVIK-UHFFFAOYSA-N raspberry ketone Chemical compound CC(=O)CCC1=CC=C(O)C=C1 NJGBTKGETPDVIK-UHFFFAOYSA-N 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- YRCWQPVGYLYSOX-UHFFFAOYSA-N synephrine Chemical compound CNCC(O)C1=CC=C(O)C=C1 YRCWQPVGYLYSOX-UHFFFAOYSA-N 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 240000004160 Capsicum annuum Species 0.000 description 1
- 235000007862 Capsicum baccatum Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 235000011511 Diospyros Nutrition 0.000 description 1
- 244000236655 Diospyros kaki Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241001247145 Sebastes goodei Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- BLGXFZZNTVWLAY-CCZXDCJGSA-N Yohimbine Natural products C1=CC=C2C(CCN3C[C@@H]4CC[C@@H](O)[C@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-CCZXDCJGSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 210000000593 adipose tissue white Anatomy 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229960002105 amrinone Drugs 0.000 description 1
- RNLQIBCLLYYYFJ-UHFFFAOYSA-N amrinone Chemical compound N1C(=O)C(N)=CC(C=2C=CN=CC=2)=C1 RNLQIBCLLYYYFJ-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- BLGXFZZNTVWLAY-UHFFFAOYSA-N beta-Yohimbin Natural products C1=CC=C2C(CCN3CC4CCC(O)C(C4CC33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229950011520 butopamine Drugs 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000001728 capsicum frutescens Substances 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001793 charged compounds Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000005686 eating Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000010437 gem Substances 0.000 description 1
- 229910001751 gemstone Inorganic materials 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- 235000021552 granulated sugar Nutrition 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 125000001072 heteroaryl group Chemical group 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940039009 isoproterenol Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 229940083747 low-ceiling diuretics xanthine derivative Drugs 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229960003574 milrinone Drugs 0.000 description 1
- PZRHRDRVRGEVNW-UHFFFAOYSA-N milrinone Chemical compound N1C(=O)C(C#N)=CC(C=2C=CN=CC=2)=C1C PZRHRDRVRGEVNW-UHFFFAOYSA-N 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 125000002811 oleoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 229960003684 oxedrine Drugs 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000955 prescription drug Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- YJQZYXCXBBCEAQ-UHFFFAOYSA-N ractopamine Chemical compound C=1C=C(O)C=CC=1C(O)CNC(C)CCC1=CC=C(O)C=C1 YJQZYXCXBBCEAQ-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- BLGXFZZNTVWLAY-SCYLSFHTSA-N yohimbine Chemical compound C1=CC=C2C(CCN3C[C@@H]4CC[C@H](O)[C@@H]([C@H]4C[C@H]33)C(=O)OC)=C3NC2=C1 BLGXFZZNTVWLAY-SCYLSFHTSA-N 0.000 description 1
- 229960000317 yohimbine Drugs 0.000 description 1
- AADVZSXPNRLYLV-UHFFFAOYSA-N yohimbine carboxylic acid Natural products C1=CC=C2C(CCN3CC4CCC(C(C4CC33)C(O)=O)O)=C3NC2=C1 AADVZSXPNRLYLV-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- Wrinkle improving agent lipolysis accelerator, composition for external use of skin and food and beverage composition
- the present invention is a wrinkle improving agent that has an effect of improving wrinkles that occur particularly at the exposed site with aging, and has an effect of keeping the skin in a dermatological and cosmetically healthy and powerful state, and
- the present invention relates to an external composition for skin containing the wrinkle improving agent.
- the present invention also provides an external composition for skin that is effective in improving obesity by promoting reduction of systemic or local adipose tissue, or suppressing or preventing obesity by preventing the increase of the same yarn and weave. And a food and beverage composition.
- Organs of all living organisms including human beings are born and grow, then gradually decline with age, eventually stop functioning, and die when a certain part of the function is over a certain level.
- the state in which the function gradually declines is called aging.
- the skin is directly affected by the surrounding environmental forces, and since it has an important function to maintain the environment inside the living body, it is not likely that all of them will stop functioning, but stains, spots, dullness, tarmi, etc. Signs of aging are manifested in a frustrating organ, especially at exposed sites exposed to sunlight.
- retinoic acid is used as a prescription drug as a substance having an improvement effect on wrinkles resulting from the progress of photoaging. So it has not been approved.
- retinol which is said to be converted into retinoic acid after being absorbed into the body and exert its effect
- ascorbic acid vitamin C
- vitamin E which has an effect of promoting antioxidant and collagen synthesis
- Tokohue with strong ⁇ effect Rolls vitamin E
- wrinkle-improving substances have the disadvantage that they do not have a satisfactory effect. Therefore, until now, there has been no material that has sufficiently satisfactory effects and safety as a substance that improves seeds.
- body fat is formed by being accumulated as fat in the white adipose tissue existing around the internal organs and subcutaneously as an excess component of intake energy with respect to consumed energy.
- So-called obesity in which body fat accumulates excessively, causes various diseases such as arteriosclerosis, which is unfavorable for cosmetic purposes, and is not preferable for health.
- arteriosclerosis which is unfavorable for cosmetic purposes, and is not preferable for health.
- obesity due to overeating, lack of movement, stress, etc. has increased, and prevention of reduction or accumulation of body fat has become an important issue.
- women tend to crave a slim and firm body from the outside.
- kabusaicins contained in red pepper and the like bind to albumin in blood and promote secretion of hormones that promote energy metabolism such as adrenal glands, and liver and fat cells It is known to activate lipolysis in dairy cattle (see Non-Patent Document 1).
- kabusaicins have strong irritation, so there was a problem when their use and usage were limited.
- raspberry ketone, gingerone and derivatives thereof promote the degradation of fat accumulated in adipose tissue, and are effective in suppressing obesity or improving obesity constitution (patent) Reference 1).
- Lasbery ketones and Zingerone have a unique fragrance! /, They are not always satisfactory in terms of blending amount and versatility.
- ginger ginger (Aframomum melegueta) grows naturally in the tropics centering on West Africa, and as a spice in the name of “Maget” or “Grainobu Paradise”. It's being used. Ginger ginger is a flavoring and flavoring dish Although it has been used as one, there have been no studies on wrinkle-improving agents or skin external compositions using the extract!
- Parador [1— (4′-hydroxy-1 3′-methoxyphenol) -1-3-decanone] has been reported as an ingredient contained in a specific fraction of the above ginger ginger seed extract Chemical formula:
- Patent Document 2 Although paradol has been proposed as a termite control agent together with other related compounds, it does not describe the improvement effect of wrinkles, the effect of promoting lipolysis or the slimming effect, etc. None of these effects has been studied so far.
- Patent Document 1 Japanese Unexamined Patent Publication No. 2000-169325
- Patent Document 2 JP-A-10-152404
- Patent Document 3 Japanese Patent No. 3164455
- Non-Patent Document 1 Iwai Kazuo and Nakatani Nobuni, “Food Function of Spice Components”, p. 97, 1989
- R is a hydrogen atom or an acyl group having 2 to 20 carbon atoms
- the present invention also provides a lipolysis promoter comprising the compound represented by the above general formula (1) as an active ingredient, an extract obtained from Ginger ginger, and Z or an acyl-treated product of the extract. It is related with the lipolysis promoter which uses as an active ingredient.
- the invention of the present application also contains an external composition for skin containing the compound represented by the above general formula (1), and an extract obtained from ginger ginger and Z or a processed product of the extract of this extract.
- the invention also relates to a composition for external use on the skin.
- the present invention further includes a food and beverage composition containing a compound represented by the above general formula (1), an extract obtained from ginger ginger, and Z or a processed product of the extract of this extract. It is related with the food-drinks composition to do.
- the wrinkle improving agent and the composition for external use of the skin of the present invention are excellent in the effect of improving wrinkles that occur especially at the exposed site with aging, and keep the skin in a dermatological and cosmetically healthy state. It is effective and has excellent safety and stability.
- the lipolysis promoter, skin external composition, and food / beverage product composition of the present invention prevent improvement of obesity by promoting reduction of systemic or local adipose tissue, or increase of the same yarn and texture. It is effective in suppressing or preventing obesity caused by the above, and because the stimuli and fragrances that impair the palatability are suppressed, the feeling of use is not only excellent in terms of palatability, but also in terms of palatability.
- the paradol used in the present invention can be easily extracted and purified from the strength of natural materials such as ginger ginger, it is also possible to obtain a composition excellent in terms of safety.
- FIG. 1 is a diagram showing a mass spectrum of purified paradol.
- FIG. 2 is a diagram showing a 13 C-NMR ⁇ vector (100 MHz, CDC1) of purified paradol.
- Ginger ginger (Afr amomum melegueta), which is a ginger family plant used in the present invention, grows naturally in the tropics centering on West Africa and is known as “Mayget” or “Grainobu Paradise” as a spice. It's being used .
- the extract used in the present invention is an extract that can be obtained by extracting a ginger ginger plant body, in particular, seeds, as an extraction material by a known method.
- the solvent used for the extraction is not particularly limited.
- lower alcohol such as methanol, ethanol, propyl alcohol, isopropyl alcohol, butanol or water-containing lower alcohol, or polyhydric alcohol such as 1,3-butylene glycol or the like.
- a water-containing polyhydric alcohol or various organic solvents such as acetone, ethyl acetate, and hexane can be used.
- the part of the plant used as the extraction material is not particularly limited, but the target is more efficiently targeted. It is preferable to use seeds because the extract is obtained.
- the obtained extract may be used as it is, or may be brought into a desired form or property by an operation such as concentration, drying or dilution, if necessary.
- the acylated product of the extract is a product obtained by subjecting the extract to extraction.
- an acylation reaction as described in the method for producing a compound represented by the following general formula (1) the extraction of guinea ginger is performed. Physical strength can also be obtained.
- the paradol used in the present invention can be obtained by hydrogenating shogaol in addition to being synthesized by using a general organic synthesis method from gingerone (Toyi Science Report I, 16, 589, 1927). There is no particular limitation on the synthesis method.
- Norador can be obtained by extracting and purifying guinea ginger, particularly its seed, as an extraction material by a known method.
- ginger ginger grows naturally in the tropics, especially in West Africa, and is available as a spice.
- organic solvents such as lower alcohols such as methanol, ethanol, propyl alcohol, isopropyl alcohol, and butanol and hydrous lower alcohols, or polyhydric alcohols such as 1,3-butylene glycol are used.
- various organic solvents such as acetone, ethyl acetate, and hexane can be used.
- a low polarity solvent such as hexane, heptane, octane and the like.
- a known purification means is used. If used, it can be purified using, for example, silica gel chromatography.
- an acyl group having 2 to 20 carbon atoms is a group R '— CO—.
- R ′ is a linear or branched alkyl group having 1 to 19 carbon atoms which may have an unsaturated bond, or an aryl group such as phenyl or naphthyl, or a nitrogen atom
- Zeo atom and oxygen nuclear power represents a heteroaryl group such as pyridyl, imidazolyl, phenyl, furyl, etc. containing a selected hetero atom as a ring member.
- These groups may have a functional group such as an amino group.
- acyl group having 2 to 20 carbon atoms include acetyl, propionyl, butyryl, isobutyryl, valeryl, hexanol, lauroyl, normitoyl, and oleoyl.
- R is an acyl group having 2 to 20 carbon atoms
- a paradol [11 (4′-hydroxy 3′-methoxyphenyl) 3-decanone] obtained by the above-described method and an acid chloride or acid anhydride having a desired acyl group are combined with pyridin. It can be easily obtained by reacting in the inside. Alternatively, it may be reacted with a carboxylic acid in the presence of a catalytic amount of a base.
- norador derivatives obtained by derivatizing norador with a known method for example, glycosylated at the hydroxyl group at the 4-position of the aromatic ring, those obtained by reducing the ketone group, etc. As an equivalent, it can be used in the present invention.
- an extract obtained from the seed and Z or an acylated product of the extract can be used as a wrinkle improving agent.
- the extract may be used as it is, or it may be brought into a desired form or property by an operation such as concentration, drying or dilution, if necessary.
- the compound represented by the general formula (1), and ginger ginger, in particular, an extract obtained from the seed and Z or an acylated product of the extract as a wrinkle improving agent are applied to the skin.
- the blended amount is based on the total amount of the composition for external use on the skin. It is particularly preferable that the blending amount when converted to paradol is 0.001 to 10.0% by mass (hereinafter simply referred to as%), preferably 0.01 to 8.0%, and more particularly preferably 0.05 to 5%, most preferably 0.1 to 3%. If the blending amount is less than 001%, the intended effect of the present invention is not sufficient.On the other hand, even if the blending amount exceeds 10.0%, the effect corresponding to the increase is not increased, which is preferable! /.
- the wrinkle improving effect when blended in a composition for external use as a wrinkle improving agent, if the ingredients such as retinol, ascorbic acid, and tocopherol, which are conventionally known to improve wrinkle, are used in combination, the wrinkle improving effect may be complemented. This is preferable because a synergistic effect can be expected.
- the compound represented by the above general formula (1), and ginger ginger, particularly an extract obtained from the seed thereof and Z or an acylated product of the extract promotes lipolysis.
- a lipolysis accelerator it can be added to a composition for external use on skin or a food or drink composition.
- compositions for external use on skin and compositions for foods and drinks using the compound represented by the general formula (1), and ginger ginger, in particular, an extract obtained from the seed thereof and Z or an acylated product of the extract as a lipolysis accelerator
- the blending amount varies depending on the form of the formulation and cannot be defined unconditionally.
- 0% by mass hereinafter simply referred to as%
- Particularly preferred is 0.01 to 8.0%, more particularly preferred is 0.05 to 5%, and most preferred is 0.1 to 3%. It is. If it is less than 001% by mass, the effects of the present invention may not be achieved. If it exceeds 10% by mass, the irritation will be strong and the sensory characteristics and palatability may be impaired.
- the intake amount per adult is 20 to L000 mg, preferably 100 to 200 mg in terms of paradole.
- composition for external use as a lipolysis promoter of the present invention or a food and drink composition includes raspberry ketone, gingerone, and other components having an action to suppress or prevent obesity.
- —Dihydroxyphenol) 2 Butanone may be combined with synephrine as appropriate to enhance its effect or reinforce it.
- composition for external use as a lipolysis accelerator of the present invention and the composition of food and drink include 13 adrenergic stimulants such as butopamine and isoproterenol, yohimbine, ergotokki
- An a2 adrenergic inhibitor such as syn, xanthine derivatives such as theophylline and caffeine, and biviridine derivatives such as milrinone and amrinone can also be added.
- the skin external composition and the food / beverage product composition of the present invention can be blended with various components that are usually used within a range that does not impair the effects of the present invention, if necessary.
- a composition for external use on the skin for example, an oil, a pigment, a fragrance, a surfactant, a moisturizer, an ultraviolet absorber, an anti-inflammatory agent, a disinfectant, a dye, an antiseptic, an antioxidant, etc.
- ingredients such as an excipient, a binder, a thickener, an emulsifier, a colorant, a fragrance, a food additive, a seasoning, etc. I can do it.
- the composition for external use of the skin of the present invention corresponds to not only skin cosmetics but also pharmaceuticals and bath agents.
- the dosage form is not particularly limited, but in the case of an external composition for skin, lotion, cream for applying to the skin, bathing or washing, emulsion, jewel, knock, stick, sheet, pap , Powder, liquid, granule and the like.
- ginger ginger extract As a result of analysis by HPLC, this ginger ginger extract contained 55% norador.
- Example 3 (Making of acetylated guinea ginger extract)
- the ginger ginger extract obtained in Production Example 1 1. Og, 1.0 ml of pyridine, and 30 ml of acetic anhydride were mixed and stirred at room temperature for 24 hours. Then, after adding water, extraction with ethyl acetate was carried out to obtain 1.2 g of an extract treated with acetylene. This processed product is hereinafter referred to as “acetylene extract ginger extract”.
- a group of 10 hairless mice aged 10 weeks at the start of the test was used.
- Photoaging was induced by UVA and UVB irradiation once a day, 5 times a week for 8 weeks. Irradiation dose, UVA is increased with 20J / cm 2, 25J / cm 2, 30J / cm 2, UVB is 20J / cm 2, 30J / cm 2, 40J / cm 2, an irradiation amount for each week, 3 After week, the maximum dose was irradiated.
- the wrinkle improvement effect was evaluated by the wrinkle score and the amount of dermal collagen.
- the scoring score was scored according to the method of Bis sett et al. (Photochem Photobiol, 46: 367-378, 1987). In other words, the size and depth of the pods are comprehensively evaluated with the naked eye, 3 for “Large and deep sight can be confirmed”, 2 for ”I can witness the crease”, and “I cannot confirm crease” 1 , “Normal texture is observed” was scored on a scale of 0 and 4.
- the amount of dermal collagen is collected by collecting all skin layers and crushing them with a polytron homogenizer (KINEMATICA), extracting the collagen fraction, acid hydrolysis, and measuring the hydroxyproline content using an amino acid analyzer (JASCO). Quantitative measurement using a The amount of hydroxyproline per 1 cm 2 was used as a relative indicator of the amount of dermal collagen
- ginger ginger extract (Production Example 1), paradol (Production Example 2) or acetylyl oyster-ginger extract (Production Example 3), 1.0% (paradol concentration 0.5%, 0.8%, acetylyl paradol concentration 0.5%, respectively) ) was prepared (Example 1, 2 or 3).
- the base alone was used as a comparative example.
- 0.1 ml of these evaluation samples are applied to the back skin (diameter of about 2.5 cm) of hairless mice once a day, 5 times a week, from the 5th week after the start of UV irradiation until the 4th week after the end of irradiation. Applied. And the score was scored after the final application. After sacrifice, the skin was collected and the collagen content (hydroxyproline amount per cm 2 ) was measured.
- the wrinkle improving agent application group containing the ginger ginger extract, paradol or acetylated ginger ginger extract of Examples 1 to 3 as an active ingredient is compared with the application group of only the base of Comparative Example 1 or 2. A low season score value was shown, indicating that the present seasoning improving agent is effective.
- the wrinkle improving agent-coated group containing the ginger ginger extract of Example 1 as an active ingredient exhibits a higher collagen content (hydroxyproline amount) than the base-only Comparative Example 1 coated group.
- the present wrinkle improving agent was shown to be effective against the amount of dermal collagen decreased by photoaging.
- This seasoning improver which contains Rui ginger ginger extract as an active ingredient, is effective for photoaging.
- Mouse 3T3-L1 cells purchased from Dainippon Pharmaceutical Co., Ltd. were placed in a 24-well culture plate according to the method of Ensler et al. (Ensler K. et al., Biochim. Biophys. Acta., 1581: 36-48 (2002) )), 5% (v / v) cultured at 37 ° C in a CO atmosphere, and used as mature adipocytes for the test.
- test medium in which the test sample is added to the DMEM medium supplemented with serum albumin and norepinephrine (final concentration 3 X 10 " 8 mol / L), and the mature adipocytes in the test medium for 90 minutes. After the reaction, glycerol released in the medium was quantified by enzyme immunoassay using F kit 'glycerol (Roche).
- the rate of accelerating lipolysis was calculated according to the following formula and used as an index of the effect of accelerating lipolysis.
- ICR mice male, 4-week-old 6 mice were used as 1 group, 2 groups were used, the control group had a high-fat diet with the following composition, and the test group was a high-fat diet obtained in Production Example 1.
- Each test sample containing 1% by weight of ginger extract was fed for 6 weeks and reared. Body weight was measured at the start of the study and 6 weeks after the start of the study, and the weight gain was used as an index to evaluate differences between groups to determine the weight gain inhibitory effect. In addition, feed and water were ingested freely.
- composition composition of high fat feed Compounding ingredients Compounding amount (% by mass) Beef tallow 40
- the amount of weight gain due to intake of a high-fat diet is significantly reduced by adding the ginger ginger extract, which is a fat degradation accelerator of the present invention, to a high-fat feed. It has been shown.
- Example 7 or 8 and Comparative Example 3 with healthy subjects with wrinkles in the corners of the eyes (female, 41 to 65 years, 10 for each of Example 7 or Example 8) as subjects Decide each lotion on either the left or right side, after washing in the morning and after bathing in the evening twice a day for 2 consecutive months (60 days). About 0.2 ml each was applied to about 4 cm 2 and 2 X 2 cm). After the final application, they were asked to answer a questionnaire regarding the condition of the skin on the left and right eye corners.
- the skin became soft 4 3
- the size of the shrimp has decreased 1 6
- the number of shrimp has decreased 7
- Tablet confectionery was produced with the following composition, and 3 tablets per day (0.5 gZ tablet) were ingested and evaluated under the same conditions as in Examples 10 and 11 above.
- the food / beverage product compositions (chewing gum and tablet confectionery) of the above examples showed a significant reduction in body fat percentage. Furthermore, the food / beverage composition of the present application was excellent in palatability immediately after ingestion, and was a food / beverage composition suitable for continuous meals that would not get tired even for a long time.
- each component A and B was separately mixed and dissolved in the composition shown below, and then the B component was added to the A component and stirred to prepare a jelly-like slimming skin cosmetic composition.
- the above-mentioned jewel-like slimming skin cosmetic was applied to each of the abdomen and thighs of 20 subjects in each group of subject panels for about 2 g twice a day for 3 weeks.
- a questionnaire was conducted. As shown in the above evaluation results, the number of persons who answered that the abdomen and thighs were tightened compared with before continuous use was far greater with the panel using the jewel-like slimming skin care cosmetic of the present invention. I worked hard.
- the present invention also relates to palatability such as aroma during use, stimulation, etc. There was no particular problem with gel-like slimming skin cosmetics.
- composition of the fragrance used in this example is shown in Table 1 below. 1]
- the present invention is excellent in improving the wrinkles that occur especially at the exposed site with aging, and has the effect of keeping the skin in a dermatological and cosmetic health and strength, as well as safety and stability.
- the present invention provides a lipolysis accelerator that is effective in suppressing or preventing obesity caused by aging, and that suppresses irritation and aroma that impairs palatability, and a composition for external use in skin and a food and drink composition containing the lipolysis accelerator. .
Abstract
Description
Claims
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES05781045.9T ES2567061T3 (es) | 2004-08-30 | 2005-08-29 | Agente reductor de las arrugas y composición para uso externo en la piel que comprende dicho agente |
CN2005800292121A CN101018537B (zh) | 2004-08-30 | 2005-08-29 | 皱纹改善剂、脂肪分解促进剂、皮肤外用组合物及饮食物组合物 |
EP05781045.9A EP1800651B1 (en) | 2004-08-30 | 2005-08-29 | Wrinkle reduction agent and composition for external use on skin comprising said agent |
US11/661,401 US20070259057A1 (en) | 2004-08-30 | 2005-08-29 | Wrinkle Reduction Agent, Lipolysis Accelerator, Composition for External Use on Skin, and Food or Beverage Composition |
JP2006532660A JP4673851B2 (ja) | 2004-08-30 | 2005-08-29 | 脂肪分解促進剤及び痩身用皮膚外用組成物 |
US12/335,326 US20090149550A1 (en) | 2004-08-30 | 2008-12-15 | Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
US13/595,215 US8445005B2 (en) | 2004-08-30 | 2012-08-27 | Antiwrinkle agent, lipolysis promoter, external composition for skin and food and beverage composition |
Applications Claiming Priority (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004-250178 | 2004-08-30 | ||
JP2004250178 | 2004-08-30 | ||
JP2004-321698 | 2004-11-05 | ||
JP2004321698 | 2004-11-05 | ||
JP2005004506 | 2005-01-11 | ||
JP2005-004506 | 2005-01-11 | ||
JP2005144765 | 2005-05-17 | ||
JP2005-144765 | 2005-05-17 | ||
JP2005-176165 | 2005-06-16 | ||
JP2005176165 | 2005-06-16 |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/661,401 A-371-Of-International US20070259057A1 (en) | 2004-08-30 | 2005-08-29 | Wrinkle Reduction Agent, Lipolysis Accelerator, Composition for External Use on Skin, and Food or Beverage Composition |
US12/335,326 Division US20090149550A1 (en) | 2004-08-30 | 2008-12-15 | Wrinkle reduction agent, lipolysis accelerator, composition for external use on skin, and food or beverage composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2006025307A1 true WO2006025307A1 (ja) | 2006-03-09 |
Family
ID=35999961
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2005/015635 WO2006025307A1 (ja) | 2004-08-30 | 2005-08-29 | シワ改善剤、脂肪分解促進剤、皮膚外用組成物及び飲食物組成物 |
Country Status (8)
Country | Link |
---|---|
US (3) | US20070259057A1 (ja) |
EP (1) | EP1800651B1 (ja) |
JP (3) | JP4673851B2 (ja) |
KR (3) | KR100885580B1 (ja) |
CN (2) | CN101632625B (ja) |
ES (1) | ES2567061T3 (ja) |
TW (1) | TWI361076B (ja) |
WO (1) | WO2006025307A1 (ja) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007238569A (ja) * | 2006-03-10 | 2007-09-20 | Kanebo Cosmetics Inc | 頭髪化粧料 |
JP2009510155A (ja) * | 2005-10-04 | 2009-03-12 | エルブイエムエイチ レシェルシェ | 植物のアフラモムムアングスチホリウム又はロンゴザの抽出物を含む、特に抗老化活性を有する化粧料組成物 |
JP2009196980A (ja) * | 2008-01-22 | 2009-09-03 | Kao Corp | メラニン生成抑制剤及び美白化粧料 |
JP2010094081A (ja) * | 2008-10-17 | 2010-04-30 | Kao Corp | 飲食品組成物 |
JP2013107888A (ja) * | 2011-11-22 | 2013-06-06 | Oneness Biotech Co | 抗関節炎活性を有するプレクトランサス・アンボイニクス画分 |
JP2014019648A (ja) * | 2012-07-12 | 2014-02-03 | Kao Corp | PPARδ活性化剤 |
JP2018501313A (ja) * | 2014-12-19 | 2018-01-18 | パラダイス・ヘルス・インコーポレイテッドParadise Health, Inc. | 血小板凝集能を低下させ、循環器疾患及び他の内科疾患を治療する方法 |
CN112457192A (zh) * | 2020-11-03 | 2021-03-09 | 桂林理工大学 | 一种姜酮酚的合成方法 |
WO2024071077A1 (ja) * | 2022-09-27 | 2024-04-04 | 富士フイルム株式会社 | 食品用組成物及び抗肥満用組成物 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2932088B1 (fr) * | 2008-06-06 | 2013-04-05 | Lvmh Rech | Utilisation d'un extrait de lepechinia caulescens comme agent cosmetique, et composition cosmetique le contenant |
US8158683B2 (en) * | 2009-03-02 | 2012-04-17 | Fhg Corporation | Dietary supplements containing extracts of aronia and methods of using same to promote weight loss |
FR2950804B1 (fr) * | 2009-10-01 | 2011-12-23 | Oreal | Composition, utilisation et procede de conservation |
FR2951079B1 (fr) | 2009-10-08 | 2012-04-20 | Oreal | Composition photoprotectrice a base d'un compose 2-alcoxy-4-alkylcetone phenol ; utilisation dudit compose pour augmenter le facteur de protection solaire |
DE102009055917A1 (de) * | 2009-11-27 | 2011-06-01 | Beiersdorf Ag | Verwendung von Zingeron gegen Altershaut |
FR2973230B1 (fr) * | 2011-04-01 | 2013-11-01 | Oreal | Utilisation de gingerone ou de ses derives pour diminuer ou retarder les signes du vieillissement de la peau |
ES2941479T3 (es) | 2012-06-15 | 2023-05-23 | Symrise Ag | Composiciones que comprenden agentes que promueven la biosíntesis de hialuronano |
JP5808772B2 (ja) * | 2013-05-13 | 2015-11-10 | 株式会社エヌ・エル・エー | 肝細胞内のミトコンドリアの活性化方法 |
CN103553889B (zh) * | 2013-10-31 | 2016-01-20 | 苏州永健生物医药有限公司 | 一种姜酮酚的合成方法 |
US20190380934A1 (en) * | 2015-12-10 | 2019-12-19 | Symrise Ag | Composition with stabilized taste and odor |
CN106187727A (zh) * | 2016-07-27 | 2016-12-07 | 陕西嘉禾生物科技股份有限公司 | 一种从天堂椒果实中提取6‑姜酮酚的方法 |
EP3299026B1 (de) * | 2016-09-22 | 2020-05-27 | Dr. Willmar Schwabe GmbH & Co. KG | Extrakte aus samen von aframomum-arten und deren verwendung |
JP7426687B2 (ja) * | 2019-07-12 | 2024-02-02 | 池田食研株式会社 | 植物抽出物及びその製造方法 |
CN113116738B (zh) * | 2019-12-31 | 2022-09-02 | 新生活化妆品科技(上海)有限公司 | 外用添加剂及其应用、皮肤外用制品 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06239736A (ja) * | 1993-02-18 | 1994-08-30 | Pola Chem Ind Inc | 角層修復促進剤 |
JPH10152404A (ja) | 1997-10-08 | 1998-06-09 | Kagaku Gijutsu Shinko Jigyodan | 新規ケトン類、その製造法及び該化合物を有効成分とするシロアリ防除剤 |
JP2000169325A (ja) | 1998-12-11 | 2000-06-20 | Kanebo Ltd | 脂肪分解促進剤及び痩身用皮膚化粧料 |
US20040067245A1 (en) * | 2000-12-20 | 2004-04-08 | Harish Mahalingam | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4826828A (en) * | 1985-04-22 | 1989-05-02 | Avon Products, Inc. | Composition and method for reducing wrinkles |
JPH02257866A (ja) * | 1989-03-31 | 1990-10-18 | San Purasuto Mikasa:Kk | 食料品保存剤 |
US5834445A (en) * | 1989-08-11 | 1998-11-10 | Sikorski; Christopher | Process for preparing decolorized carotenoid-cyclodextrin complexes |
EP0555309A1 (en) | 1990-10-31 | 1993-08-18 | BEECHAM GROUP plc | Topical composition with retinoid penetration enhancer |
US6063381A (en) * | 1993-05-19 | 2000-05-16 | Staggs; Jeff J. | Therapeutic uses of pungent botanicals and their related compounds |
JPH11508593A (ja) * | 1995-07-05 | 1999-07-27 | ザ、プロクター、エンド、ギャンブル、カンパニー | 加温化合物 |
KR19990025049A (ko) * | 1997-09-10 | 1999-04-06 | 서경배 | 발암억제작용을 갖는 생강과 익지인의 활성성분들 및 이를 함유하는 조성물 |
CN100453531C (zh) * | 1998-10-09 | 2009-01-21 | 味之素株式会社 | 半胱氨酸衍生物 |
KR20010018659A (ko) | 1999-08-20 | 2001-03-15 | 유상옥 | 울금 추출물을 함유하는 화장료 조성물 |
JP2001131046A (ja) * | 1999-11-04 | 2001-05-15 | Pola Chem Ind Inc | 過酸化水素消去剤及びこれを含有する化粧料。 |
JP2002275077A (ja) * | 2001-01-11 | 2002-09-25 | Kanebo Ltd | リパーゼ阻害剤 |
US7025985B2 (en) * | 2001-05-28 | 2006-04-11 | Kanebo, Ltd. | Dihydroxyphenyl compounds and glucoside compounds thereof |
EP1323356B1 (de) * | 2001-12-27 | 2006-03-15 | Symrise GmbH & Co. KG | Verwendung von Ferulasäureamiden als Aromastoffe |
US20040156799A1 (en) * | 2002-06-04 | 2004-08-12 | Zigang Dong | Cancer treatment method and compositions |
KR100920961B1 (ko) * | 2002-06-25 | 2009-10-09 | 가부시키가이샤 시세이도 | 항노화제 |
KR100499703B1 (ko) * | 2002-08-07 | 2005-07-07 | 백승화 | 생강추출액을 함유하는 기능성 음료 |
JP2004107250A (ja) | 2002-09-18 | 2004-04-08 | Kanebo Ltd | 敏感肌改善剤、神経成長因子生成抑制剤及び敏感肌改善用皮膚外用組成物 |
US20050136028A1 (en) * | 2003-12-19 | 2005-06-23 | Dmitri Ptchelintsev | Cosmetic compositions having extracts of Amomum melegueta and methods of treating skin |
US20050260290A1 (en) * | 2004-05-20 | 2005-11-24 | Rutgers, The State University Of New Jersey | Botanical anti-inflammatory compositions and methods |
-
2005
- 2005-08-29 CN CN2009101662412A patent/CN101632625B/zh not_active Expired - Fee Related
- 2005-08-29 CN CN2005800292121A patent/CN101018537B/zh not_active Expired - Fee Related
- 2005-08-29 KR KR1020087010322A patent/KR100885580B1/ko active IP Right Grant
- 2005-08-29 WO PCT/JP2005/015635 patent/WO2006025307A1/ja active Application Filing
- 2005-08-29 EP EP05781045.9A patent/EP1800651B1/en not_active Expired - Fee Related
- 2005-08-29 TW TW094129512A patent/TWI361076B/zh not_active IP Right Cessation
- 2005-08-29 KR KR1020087024184A patent/KR20080093167A/ko not_active Application Discontinuation
- 2005-08-29 ES ES05781045.9T patent/ES2567061T3/es active Active
- 2005-08-29 JP JP2006532660A patent/JP4673851B2/ja not_active Expired - Fee Related
- 2005-08-29 KR KR1020077007138A patent/KR100882618B1/ko active IP Right Grant
- 2005-08-29 US US11/661,401 patent/US20070259057A1/en not_active Abandoned
-
2008
- 2008-12-15 US US12/335,326 patent/US20090149550A1/en not_active Abandoned
-
2010
- 2010-03-26 JP JP2010071444A patent/JP4819171B2/ja active Active
- 2010-09-06 JP JP2010198531A patent/JP2011016827A/ja active Pending
-
2012
- 2012-08-27 US US13/595,215 patent/US8445005B2/en not_active Expired - Fee Related
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH06239736A (ja) * | 1993-02-18 | 1994-08-30 | Pola Chem Ind Inc | 角層修復促進剤 |
JP3164455B2 (ja) | 1993-02-18 | 2001-05-08 | ポーラ化成工業株式会社 | 角層修復促進剤 |
JPH10152404A (ja) | 1997-10-08 | 1998-06-09 | Kagaku Gijutsu Shinko Jigyodan | 新規ケトン類、その製造法及び該化合物を有効成分とするシロアリ防除剤 |
JP2000169325A (ja) | 1998-12-11 | 2000-06-20 | Kanebo Ltd | 脂肪分解促進剤及び痩身用皮膚化粧料 |
US20040067245A1 (en) * | 2000-12-20 | 2004-04-08 | Harish Mahalingam | Cosmetic compositions and methods for using same to improve the aesthetic appearance of skin |
Non-Patent Citations (5)
Title |
---|
BISSETT ET AL., PHOTOCHEM. PHOTOBIOL., vol. 46, 1987, pages 367 - 378 |
CHUNG W.-Y. ET AL: "Antioxidative and antitumor promoting effects of [6]-paradol and its homologs", MUTATION RESEARCH, vol. 496, no. 1-2, 2001, pages 199 - 206, XP001119851 * |
IWAI, K. AND NAKATANI, N.,: "Food Functions of Spice Components", vol. 97, 1989 |
KISLALIOGLU M.S.: "Causes, clinical features and management of skin aging", HOUSEHOLD AND PERSONAL PRODUCTS INDUSTRY, vol. 31, no. 5, 1994, pages 61 - 62,64,66,68,70,72,74,76,78,80,82, XP002993893 * |
See also references of EP1800651A4 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009510155A (ja) * | 2005-10-04 | 2009-03-12 | エルブイエムエイチ レシェルシェ | 植物のアフラモムムアングスチホリウム又はロンゴザの抽出物を含む、特に抗老化活性を有する化粧料組成物 |
JP2007238569A (ja) * | 2006-03-10 | 2007-09-20 | Kanebo Cosmetics Inc | 頭髪化粧料 |
JP2009196980A (ja) * | 2008-01-22 | 2009-09-03 | Kao Corp | メラニン生成抑制剤及び美白化粧料 |
JP2010094081A (ja) * | 2008-10-17 | 2010-04-30 | Kao Corp | 飲食品組成物 |
JP2013107888A (ja) * | 2011-11-22 | 2013-06-06 | Oneness Biotech Co | 抗関節炎活性を有するプレクトランサス・アンボイニクス画分 |
JP2014019648A (ja) * | 2012-07-12 | 2014-02-03 | Kao Corp | PPARδ活性化剤 |
JP2018501313A (ja) * | 2014-12-19 | 2018-01-18 | パラダイス・ヘルス・インコーポレイテッドParadise Health, Inc. | 血小板凝集能を低下させ、循環器疾患及び他の内科疾患を治療する方法 |
US11110146B2 (en) | 2014-12-19 | 2021-09-07 | Paradise Health, Inc. | Methods for reducing platelet aggregation and treating cardiovascular disease and other medical disorders |
CN112457192A (zh) * | 2020-11-03 | 2021-03-09 | 桂林理工大学 | 一种姜酮酚的合成方法 |
CN112457192B (zh) * | 2020-11-03 | 2023-03-14 | 桂林理工大学 | 一种姜酮酚的合成方法 |
WO2024071077A1 (ja) * | 2022-09-27 | 2024-04-04 | 富士フイルム株式会社 | 食品用組成物及び抗肥満用組成物 |
Also Published As
Publication number | Publication date |
---|---|
KR20080093167A (ko) | 2008-10-20 |
CN101632625A (zh) | 2010-01-27 |
EP1800651A1 (en) | 2007-06-27 |
ES2567061T3 (es) | 2016-04-19 |
KR100885580B1 (ko) | 2009-02-24 |
EP1800651A4 (en) | 2011-05-11 |
CN101018537A (zh) | 2007-08-15 |
JP2010227098A (ja) | 2010-10-14 |
CN101632625B (zh) | 2011-05-11 |
US20120322888A1 (en) | 2012-12-20 |
TW200612974A (en) | 2006-05-01 |
EP1800651B1 (en) | 2016-03-09 |
JP4819171B2 (ja) | 2011-11-24 |
TWI361076B (en) | 2012-04-01 |
KR100882618B1 (ko) | 2009-02-06 |
JPWO2006025307A1 (ja) | 2008-05-08 |
US8445005B2 (en) | 2013-05-21 |
JP4673851B2 (ja) | 2011-04-20 |
KR20080050529A (ko) | 2008-06-05 |
US20070259057A1 (en) | 2007-11-08 |
KR20070056132A (ko) | 2007-05-31 |
CN101018537B (zh) | 2010-12-08 |
JP2011016827A (ja) | 2011-01-27 |
US20090149550A1 (en) | 2009-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4819171B2 (ja) | シワ改善剤、脂肪分解促進剤、皮膚外用組成物及び飲食物組成物 | |
JP6196346B2 (ja) | リグナン系化合物の皺改善用途 | |
WO2005105126A1 (ja) | 野生種スイカ抽出物を含有する活性酸素消去剤ならびに保湿剤 | |
KR20140012456A (ko) | 아케비아 사포닌-디를 포함하는 피부 상태 개선용 조성물 | |
JP2001026530A (ja) | 美白剤 | |
JP2009196980A (ja) | メラニン生成抑制剤及び美白化粧料 | |
JP4325908B2 (ja) | 脂肪分解促進剤ならびにそれを用いた皮膚外用剤および飲食物 | |
WO2008113450A2 (de) | Verwendung von chroman-4-on-derivaten | |
JP6076832B2 (ja) | メントール誘導体、並びにこれを用いた冷感剤、trpm8活性化剤、冷感付与方法及びtrpm8活性化方法 | |
JP6249516B2 (ja) | トランスグルタミナーゼ活性化剤 | |
JP5419258B2 (ja) | 化粧料 | |
JP4630052B2 (ja) | 脂肪分解促進剤、皮膚外用組成物及び飲食品組成物 | |
CN104717957B (zh) | 包含藜芦酸或其盐作为有效成分的皮肤状态改善用组合物 | |
JP2011231056A (ja) | セラミド産生促進剤及び保湿剤 | |
KR100930592B1 (ko) | 반대해 추출물을 함유하는 피부 미백 및 항산화 조성물 | |
JPWO2004089393A1 (ja) | 光老化防御剤、光老化改善剤、コラゲナーゼ阻害剤及びチロシナーゼ阻害剤 | |
JP2006248909A (ja) | レーザー光を照射して得られるラジカル消去作用を呈する抗炎症剤、それを含有する食品製剤、化粧品製剤 | |
JP2003306421A (ja) | メラノサイトのデンドライト伸長抑制剤及びそれを含有してなる皮膚外用剤 | |
JPH0640896A (ja) | メラニン生成抑制剤及びこれを含有する化粧料 | |
JP2012167022A (ja) | セラミド産生促進剤、保湿剤及び皮膚外用剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006532660 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2005781045 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11661401 Country of ref document: US Ref document number: 200580029212.1 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020077007138 Country of ref document: KR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWP | Wipo information: published in national office |
Ref document number: 2005781045 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 11661401 Country of ref document: US |